Latest Bayer News & Updates

See the latest news and media coverage for Bayer. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bayer

Life science company in healthcare and agriculture

bayer.com

Headquarters: Leverkusen, Germany
Company type: Public company
Number of employees: 96,000+
Industry: Pharmaceuticals

Last updated Yesterday

Latest news about Bayer

In short: Bayer won a Roundup trial as Nubeqa data showed 58% lower prostate cancer metastasis risk.

Company announcements

Yesterday Bayer

Bayer wins Roundup lawsuit in Missouri court

Monsanto secures unanimous defense verdict against three plaintiffs on design defect, fraud and negligence claims post-SCOTUS Durnell ruling

October 2 Bayer

Bayer invests 2.2 billion dollars in new US manufacturing site

The Ohio facility creates 600 jobs and expands R&D capabilities by 2034, reinforcing long-term growth.

September 17 Bayer

Bayer Kerendia receives FDA approval for new CKD indication in type 1 diabetes

This marks the first such treatment in over three decades and represents the third approved indication for the drug. The approval follows positive Phase III trial results.

September 9 Bayer

Bayer receives FDA accelerated approval for sevabertinib

This targeted therapy serves as a first-line option for adults with HER2-mutant non-small cell lung cancer based on Phase I/II SOHO-01 trial data.

Media coverage

Yesterday Reuters

Bayer wins US trial in which it was alleged that Roundup caused cancer in three women

Bayer ‌won a US court ⁠trial on Thursday over claims by three women ‌that ⁠Roundup had caused their ⁠cancer cases.

October 29 Finanznachrichten

Bayer regains medical imagination

Bayer is currently providing investors with several reasons to revalue the company. Positive trial data for the cancer drug darolutamide, an important approval for asundexian in China...

October 29 Bloomberg

Bayer Targets Nitrogen-Fixing Crops With UC Davis Gene Editing Technology

The company licenses UC Davis technology to edit grain DNA for air nitrogen absorption, aiming to reduce fertilizer dependency.

October 26 Bloomberg

Bayer secures China approval for stroke drug Asundexian

The German pharma giant's unit gains regulatory clearance for Asundexian in China to bolster its pipeline against generic competition.

Never miss news about Bayer

Track Bayer and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bayer competitors & trending companies

Browse news for competitors to Bayer and other trending companies.